Showing results (531-540 of 561) with videos related to
Sort By:
Pageof 57
Health Economics, Policy, and Law|January 7, 2025
Just informal patient payments are not enough, 'personal connections' and knowledge of the 'rules' are also required: a logistic regression analysis of informal practices in health care in UkraineOlena Levenets, Tetiana Stepurko, Abel Polese, et al.Health Economics, Policy, and Law|January 7, 2025
The prevalence and consequences of support for off-label Ozempic prescriptionsTimothy Callaghan, Matthew Motta, Michael Stein, et al.Health Economics, Policy, and Law|January 30, 2025
How should medicines reimbursement work? The views of Spanish expertsJuan Carlos Rejon-Parrilla, David Epstein, Daniel Pérez-Troncoso, et al.Health Economics, Policy, and Law|December 12, 2024
Exploring the uptake of economic evaluation in Spanish reports positioning medicines for public reimbursementLaura Vallejo-Torres, Juan Oliva-Moreno, Félix LoboHealth Economics, Policy, and Law|December 11, 2024
The impact of surprise billing laws on hospital-based physician prices and network participationChristopher Garmon, Yiting Li, Sheldon M Retchin, et al.Health Economics, Policy, and Law|September 11, 2023
New governance of the digital health agency: a way out of the joint decision trap to implement electronic health records in Germany?Tugce SchmittHealth Economics, Policy, and Law|September 14, 2023
Promoting the systematic use of real-world data and real-world evidence for digital health technologies across Europe: a consensus frameworkDivya Srivastava, Cornelia Henschke, Lotta Virtanen, et al.Health Economics, Policy, and Law|September 7, 2023
Financial risk protection in private health insurance: empirical evidence on catastrophic and impoverishing spending from Germany's dual insurance systemPhilipp Hengel, Miriam Blümel, Martin Siegel, et al.Health Economics, Policy, and Law|August 22, 2023
Improving access to healthcare in Ireland: an implementation failureSheelah ConnollyHealth Economics, Policy, and Law|August 14, 2023
Ten years of German benefit assessment: price analysis for drugs with unproven additional benefitKatrin Kleining, Jan Laufenberg, Philip Thrun, et al.Pageof 57